Director, Financial Planning & Analysis, Business Development

Director, Financial Planning & Analysis, Business Development

Alnylam Pharmaceuticals is seeking a Director of Business Development FP&A to serve as a senior, finance-focused partner within the Business Development Finance organization. This role is intended for a highly analytical, enterprise-minded finance professional who leads through rigorous analysis and sound financial judgment, supports external growth and enterprise initiatives, and provides disciplined decision support across a large, global biotech organization. The role includes oversight and development of one direct report and is best suited for candidates seeking continued growth within Finance.

Key Responsibilities:

• Lead and execute financial evaluations in support of the Business Development organization, including valuation modeling, scenario and sensitivity analyses, and comparable transaction benchmarking
• Deliver hands-on financial analyses for potential and existing alliances and partnerships to support strategic reviews, business cases, and long-range planning
• Oversee, review, and coach one direct report, ensuring high-quality financial models, sound assumptions, and consistent analytical standards
• Serve on deal teams, providing valuation, diligence, and analytical support throughout the transaction lifecycle while maintaining independent financial judgment
• Review term sheets and contracts, advising on financial aspects and key provisions, and coordinate input from Accounting, Tax, Treasury, and other finance functions to ensure a comprehensive and consistent financial perspective
• Partner with senior leaders across R&D, Technical Operations, and Commercial to translate complex business questions into financial frameworks and decision-ready analyses
• Lead and execute finance-led strategic analyses for the Executive Leadership Team (ELT), delivering clear, data-driven insights to support enterprise strategic and operational decisions
• Synthesize analyses into actionable, finance-grounded recommendations that inform strategic planning, capital allocation, and operational improvement initiatives
• Directly manage and develop one finance professional, providing coaching, technical guidance, and performance feedback
• Contribute to the development and continuous improvement of tools, templates, and best practices that elevate analytical rigor and consistency across the Finance organization

Qualifications:

• Bachelor's Degree in Finance or other degrees with quantitative focus (e.g. Statistics, Economics, Mathematics) required. MBA, CFA, or equivalent strongly preferred
• A minimum of 10+ years of progressive experience in Finance within biotech, pharma, or life sciences
• Strong business acumen with deep FP&A experience supporting business development functions required
• Strong understanding of financial models, valuations, and business proposals
• Ability to manage multiple priorities and deliver high-quality work under tight timelines
• Demonstrated ability to influence and communicate effectively with senior stakeholders in a matrixed environment
• Demonstrated ability to translate complex financial information and assumptions into effective presentations
• Advanced financial modeling and valuation skills — ability to build and interpret discounted cash flow (DCF), NPV, IRR, and scenario-based models for BD and strategic decisions
• Strong intellectual curiosity and initiative – proactively identifying opportunities for optimization or insight generation
• Strong collaboration skills, with an ability to inspire and motivate teams
• Excellent analytical, strategic planning, and problem-solving skills
• Thrives in a fast-paced, matrixed environment where priorities shift and collaboration is key
• Attention to detail and high standards of analytical accuracy under tight timelines
• Ability to influence and build relationships at all levels of the organization

U.S. Pay Range $ - $

About Alnylam:

We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning…